| Disease | Neuroendocrine—other |
| Stage of disease/treatment | Metastatic/advanced |
| Prior therapy | At least 1 prior regimen |
| Type of study | Phase I, 3 + 3 |
| Primary endpoints | Safety, tolerability |
| Secondary endpoints | |
| Investigator's analysis | Active and should be pursued further |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.